Year archive

Kontafarma China Holdings Limited — 2018 filings

All 59 regulatory filings released by Kontafarma China Holdings Limited (1312) in 2018, sourced directly from the official regulator.

59 Filings

2018 Period

2018 filings (59)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT POSSIBLE CHANGE IN SHAREHOLDING OF AN INDIRECT MINORITY SHAREHOLDER OF THE COMPANY Regulatory Filings	2018-12-31	English
Terms of Reference of Remuneration Committee Remuneration Information	2018-12-28	English
Terms of Reference of Nomination Committee Governance Information	2018-12-28	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30th November, 2018 Share Issue/Capital Change	2018-12-04	English
VOLUNTARY ANNOUNCEMENT PATENT COOPERATION TREATY PATENT APPLICATION Regulatory Filings	2018-11-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31st October, 2018 Share Issue/Capital Change	2018-11-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30th September, 2018 Capital/Financing Update	2018-10-03	English
LAPSE OF THE DISPOSAL AGREEMENT IN RELATION TO THE DISPOSAL OF THE ENTIRE INTEREST IN A WHOLLY-OWNED SUBSIDIARY Regulatory Filings	2018-10-01	English
INTERIM REPORT 2018 Interim / Quarterly Report H1 2018	2018-09-27	English
Next Day Disclosure Return Transaction in Own Shares	2018-09-14	English
Next Day Disclosure Return Transaction in Own Shares	2018-09-12	English
Next Day Disclosure Return Transaction in Own Shares	2018-09-11	English
Next Day Disclosure Return Transaction in Own Shares	2018-09-10	English
Next Day Disclosure Return Transaction in Own Shares	2018-09-07	English
VOLUNTARY ANNOUNCEMENT ON-MARKET SHARE BUY-BACK Transaction in Own Shares	2018-09-06	English
Next Day Disclosure Return Transaction in Own Shares	2018-09-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31st August, 2018 Capital/Financing Update	2018-09-05	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2018-09-03	English
RESIGNATION OF EXECUTIVE DIRECTOR Board/Management Information	2018-09-03	English
UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2018 Interim / Quarterly Report H1 2018	2018-09-02	English
FURTHER EXTENSION OF LONG STOP DATE OF THE MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE INTEREST IN A WHOLLY-OWNED SUBSIDIARY Regulatory Filings	2018-08-31	English
POSITIVE PROFIT ALERT Earnings Release H1 2018	2018-08-27	English
FURTHER DELAY IN DESPATCH OF CIRCULAR FOR THE MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE INTEREST IN A WHOLLY-OWNED SUBSIDIARY Regulatory Filings	2018-08-24	English
DATE OF BOARD MEETING Report Publication Announcement	2018-08-20	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31st July, 2018 Share Issue/Capital Change	2018-08-06	English
EXTENSION OF LONG STOP DATE OF THE MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE INTEREST IN A WHOLLY-OWNED SUBSIDIARY Capital/Financing Update	2018-07-31	English
DELAY IN DESPATCH OF CIRCULAR FOR THE MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE INTEREST IN A WHOLLY-OWNED SUBSIDIARY Regulatory Filings	2018-07-23	English
DELAY IN DESPATCH OF CIRCULAR FOR THE MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE INTEREST IN A WHOLLY-OWNED SUBSIDIARY Regulatory Filings	2018-07-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30th June, 2018 Capital/Financing Update	2018-07-04	English
MAJOR TRANSACTION DISPOSAL OF THE ENTIRE INTEREST IN A WHOLLY-OWNED SUBSIDIARY M&A Activity	2018-06-27	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 6 JUNE 2018 Declaration of Voting Results & Voting Rights Announcements	2018-06-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31st May, 2018 Regulatory Filings	2018-06-05	English
COMPLETION OF DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF REMAINING 40% EQUITY INTEREST IN TONGFANG PHARMACEUTICAL INVOLVING THE ISSUE OF CONSIDERATION SHARES UNDER SPECI Capital/Financing Update	2018-05-03	English
Next Day Disclosure Return Share Issue/Capital Change	2018-05-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30th April, 2018 Capital/Financing Update	2018-05-03	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2018-04-26	English
ANNUAL GENERAL MEETING FORM OF PROXY AGM Information	2018-04-26	English
PROPOSALS FOR RE-ELECTION OF DIRECTORS, GENERAL MANDATES TO ISSUE SECURITIES AND BUY BACK SHARES, AND NOTICE OF ANNUAL GENERAL MEETING AGM Information	2018-04-26	English
ANNUAL REPORT 2017 Annual Report FY 2017	2018-04-26	English
DISCLOSEABLE AND CONNECTED TRANSACTION EXTENSION OF LOANS Capital/Financing Update	2018-04-24	English
DISCLOSEABLE TRANSACTION IN RELATION TO THE PROVISION OF LOAN Capital/Financing Update	2018-04-24	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31st March, 2018 Share Issue/Capital Change	2018-04-09	English
ANNOUNCEMENT OF AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2017 Annual Report FY 2017	2018-03-28	English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 16 MARCH 2018 Declaration of Voting Results & Voting Rights Announcements	2018-03-16	English
VOLUNTARY ANNOUNCEMENT Regulatory Filings	2018-03-16	English
VOLUNTARY ANNOUNCEMENT Regulatory Filings	2018-03-15	English
DATE OF BOARD MEETING Regulatory Filings	2018-03-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28th February, 2018 Capital/Financing Update	2018-03-06	English
FURTHER ANNOUNCEMENT IN RELATION TO DISCLOSEABLE TRANSACTION AND CONTINUING CONNECTED TRANSACTION RELATING TO THE FRANCHISE AGREEMENT Regulatory Filings	2018-03-05	English
NOTICE OF EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2018-02-26	English
FORM OF PROXY Proxy Solicitation & Information Statement	2018-02-26	English
DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF REMAINING 40% EQUITY INTEREST IN TONGFANG PHARMACEUTICAL INVOLVING THE ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE AND Proxy Solicitation & Information Statement	2018-02-26	English
DELAY IN DESPATCH OF CIRCULAR FOR THE DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF REMAINING 40% EQUITY INTEREST IN TONGFANG PHARMACEUTICAL GROUP CO., LTD* INVOLVING THE IS Regulatory Filings	2018-02-13	English
Next Day Disclosure Return Share Issue/Capital Change	2018-02-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31st January, 2018 Regulatory Filings	2018-02-05	English
(I) ISSUE OF NEW SHARES UNDER GENERAL MANDATE AND (II) DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF REMAINING 40% EQUITY INTEREST IN TONGFANG PHARMACEUTICAL GROUP CO., Capital/Financing Update	2018-01-23	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2018-01-23	English
RESIGNATION OF NON-EXECUTIVE DIRECTOR AND APPOINTMENT OF EXECUTIVE DIRECTOR Board/Management Information	2018-01-23	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31st December, 2017 Capital/Financing Update	2018-01-03	English

Filings by year

2026 23 filings
2025 49 filings
2024 40 filings
2023 36 filings
2022 48 filings
2021 46 filings
2020 38 filings
2019 39 filings
2018 59 filings
2017 37 filings
2016 52 filings
2015 32 filings
2014 65 filings
2013 30 filings
2012 46 filings
2011 7 filings